Get all your news in one place.
100's of premium titles.
One app.
Start reading
Zenger
Zenger
Andre Johnson

Big Pharma’s Monopoly On Ozempic Threatens Access To Diabetes Drug In Communities Of Color

Boxes of the diabetes drug Ozempic rest on a pharmacy counter in April 2023 in Los Angeles, California. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes-who risk serious health consequences without medication. In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight loss benefits, which has led to shortages. Some doctors prescribe Ozempic off-label to treat obesity. MARIO TAMA/GETTY IMAGES.

Black Americans suffer from obesity at disproportionate rates, but the popular weight-loss drug Ozempic isn’t available in many inner-city neighborhoods.

 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.